#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories

Impossible d'ajouter des articles

Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.

Veuillez réessayer plus tard

Échec de l’élimination de la liste d'envies.

Veuillez réessayer plus tard

Impossible de suivre le podcast

Impossible de ne plus suivre le podcast

#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.

What you'll get out of this episode:

Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
The company’s patented technology improves absorption via buccal and GI routes.
First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.

To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/

Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/

BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !

Aucun commentaire pour le moment